Back to Selection     Print       Date : 30 Jun 2025
Fund Summary
Baroda BNP Paribas Large and Mid Cap Fund Reg (G)
[Equity: Large & Mid Cap]  
 
Fund Details
Fund Type Growth Launch Date 04-Sep-2020
Corpus(Cr.) 1650.0 Latest NAV 26.7421 As on 30-07-2025
Equity(%) 95.53 52 Week High 29.0249
Debt(%) 4.47 52 Week Low 23.235
Others(%) 0.0 Exit Load -
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 2.10
Scheme Benchmark BSE 250 Large MidCap TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Kirtan Mehta
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks long term capital growth through investments in both large cap and mid cap stocks.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 24.20%
Top 10 Holdings 39.33%
Top 25 Holdings 72.35%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Banking & Financial 26.58
Pharma & Biotech 8.25
Software & Services 7.54
Petroleum Products 5.65
Telecom 4.81
Energy 4.68
Cash 4.47
Automobile 4.31
Miscellaneous 4.04
Construction 3.21
Retail 3.19
Finance & Investments 3.0
Consumer Durables 2.97
Textiles 2.69
SERVICES 2.3
Industrial Products 2.22
Food Beverage & Tobacco 2.13
Oil & GAS 2.04
Technology 1.84
Transportation 1.81
Healthcare 1.16
Agricultural & Farm Machinery 1.11
 
 
 
 
 
Portfolio Metrics
PB Ratio 4.01
PE Ratio 27.08
 
Top 25 Holdings
Holdings Net Asset(%)
HDFC Bank Limited 6.67
Clearing Corporation of India Limited 5.35
ICICI Bank Limited 5.26
Bharti Airtel Limited 3.53
CRISIL 3.39
KOTAK MAHINDRA BANK LTD.-31-Jul-2025 3.28
Federal Bank Limited 3.16
Shriram Finance Limited 3.00
Hindustan Petroleum Corp. Ltd. 2.92
Infosys Limited 2.77
Reliance Industries Limited 2.73
PAGE INDUSTRIES 2.69
Sun Pharmaceutical Industries Limited 2.54
Indian Hotels Co Ltd 2.30
Kaynes Technology India Limited 2.22
Britannia Industries Limited 2.13
Bank of Baroda 2.11
GE T&D INDIA LIMITED 2.07
Eicher Motors Limited 2.06
DIVI LABORATORIES LTD. 2.06
Oil India Limited 2.04
ICICI LOMBARD GENERAL INSURANC 2.04
PNB Housing Finance Limited 2.02
Concord Biotech Limited 2.01
Max Financial Services Limited 2.00

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-2.75% 4.05% 5.98% -2.30%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
-2.43% 2.80% 7.76% 1.27%
 
Scheme Benchmark [NSE - Nifty Large Midcap 250 TRI]
-2.16% 5.88% 9.44% -0.34%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
20.04% 19.39% 0.00% 0.00%
 
 
13.82% 14.44% 18.90% 12.79%
 
 
20.11% 19.96% 24.96% 15.56%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
 
Back to Selection